| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | FAD binding | 2.39e-05 | 44 | 157 | 5 | GO:0071949 | |
| GeneOntologyMolecularFunction | intracellular sodium-activated potassium channel activity | 6.14e-05 | 2 | 157 | 2 | GO:0005228 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 9.88e-05 | 94 | 157 | 6 | GO:0050660 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP13A4 MCM6 AK9 DHX30 MFSD2A LONP1 KIF3B MOCS3 DNAH17 SMARCA2 NAV2 SMARCA4 DDX23 ABCC2 SMC1B | 1.04e-04 | 614 | 157 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | kinase activity | NAGK GRK4 GRK6 AK9 CHKB CCND3 JAK1 AURKC LRGUK NRBP2 FASTK UHMK1 DGKI PRKDC ATM PLK3 STK25 | 1.11e-04 | 764 | 157 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | snoRNA binding | 1.42e-04 | 34 | 157 | 4 | GO:0030515 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | NAGK GRK4 GRK6 CRPPA AK9 CHKB CCND3 JAK1 AURKC LRGUK NRBP2 MOCS3 FASTK UHMK1 DGKI PRKDC ATM PLK3 STK25 | 1.48e-04 | 938 | 157 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 1.83e-04 | 3 | 157 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.83e-04 | 3 | 157 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | NAGK GRK4 GRK6 CHKB CCND3 JAK1 AURKC NRBP2 FASTK UHMK1 DGKI PRKDC ATM PLK3 STK25 | 4.86e-04 | 709 | 157 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 6.05e-04 | 5 | 157 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP13A4 MCM6 AK9 DHX30 LONP1 KIF3B NAV2 SMARCA4 DDX23 ABCC2 SMC1B | 7.51e-04 | 441 | 157 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | GRK4 GRK6 CCND3 AURKC NRBP2 FASTK UHMK1 PRKDC ATM PLK3 STK25 | 8.24e-04 | 446 | 157 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | biotin binding | 9.03e-04 | 6 | 157 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 1.26e-03 | 7 | 157 | 2 | GO:0004703 | |
| Domain | ARM-type_fold | CAND1 CAND2 PKP4 INTS1 USP24 APOB DNAAF5 AP4E1 PPP2R1B NBEAL2 EIF3K PRKDC ATM | 3.62e-06 | 339 | 150 | 13 | IPR016024 |
| Domain | - | LRRC75B PRAMEF10 FBXL12 LRRIQ4 LRRC58 STK11IP NLRP2 LRGUK IGFALS LRRC1 PODN CFAP410 | 1.12e-05 | 321 | 150 | 12 | 3.80.10.10 |
| Domain | L_dom-like | LRRC75B PRAMEF10 FBXL12 LRRIQ4 LRRC58 STK11IP NLRP2 LRGUK IGFALS LRRC1 PODN CFAP410 | 1.39e-05 | 328 | 150 | 12 | IPR032675 |
| Domain | HEAT | 4.05e-05 | 48 | 150 | 5 | PF02985 | |
| Domain | Gln-Leu-Gln_QLQ | 6.41e-05 | 2 | 150 | 2 | IPR014978 | |
| Domain | SnAC | 6.41e-05 | 2 | 150 | 2 | PF14619 | |
| Domain | QLQ | 6.41e-05 | 2 | 150 | 2 | SM00951 | |
| Domain | QLQ | 6.41e-05 | 2 | 150 | 2 | PS51666 | |
| Domain | SnAC | 6.41e-05 | 2 | 150 | 2 | SM01314 | |
| Domain | SnAC | 6.41e-05 | 2 | 150 | 2 | IPR029295 | |
| Domain | TATA-bd_TIP120 | 6.41e-05 | 2 | 150 | 2 | IPR013932 | |
| Domain | QLQ | 6.41e-05 | 2 | 150 | 2 | PF08880 | |
| Domain | TIP120 | 6.41e-05 | 2 | 150 | 2 | PF08623 | |
| Domain | Leu-rich_rpt | LRRC75B LRRIQ4 LRRC58 STK11IP NLRP2 LRGUK IGFALS LRRC1 PODN CFAP410 | 6.90e-05 | 271 | 150 | 10 | IPR001611 |
| Domain | PNMA | 7.99e-05 | 11 | 150 | 3 | IPR026523 | |
| Domain | PNMA | 7.99e-05 | 11 | 150 | 3 | PF14893 | |
| Domain | HEAT | 1.02e-04 | 58 | 150 | 5 | IPR000357 | |
| Domain | Vitellinogen_superhlx | 1.91e-04 | 3 | 150 | 2 | IPR011030 | |
| Domain | LRR | 2.23e-04 | 201 | 150 | 8 | PS51450 | |
| Domain | HEAT_REPEAT | 2.49e-04 | 70 | 150 | 5 | PS50077 | |
| Domain | HSA | 3.80e-04 | 4 | 150 | 2 | SM00573 | |
| Domain | HSA | 3.80e-04 | 4 | 150 | 2 | PS51204 | |
| Domain | BK_channel_a | 3.80e-04 | 4 | 150 | 2 | PF03493 | |
| Domain | K_chnl_Ca-activ_BK_asu | 3.80e-04 | 4 | 150 | 2 | IPR003929 | |
| Domain | HSA_dom | 3.80e-04 | 4 | 150 | 2 | IPR014012 | |
| Domain | HSA | 3.80e-04 | 4 | 150 | 2 | PF07529 | |
| Domain | - | 6.07e-04 | 21 | 150 | 3 | 3.30.230.10 | |
| Domain | - | 6.31e-04 | 5 | 150 | 2 | 3.30.43.10 | |
| Domain | FAD-bd_2_sub1 | 6.31e-04 | 5 | 150 | 2 | IPR016167 | |
| Domain | FATC | 6.31e-04 | 5 | 150 | 2 | PF02260 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 6.99e-04 | 22 | 150 | 3 | IPR014721 | |
| Domain | TPR_8 | 8.62e-04 | 53 | 150 | 4 | PF13181 | |
| Domain | BRK | 9.41e-04 | 6 | 150 | 2 | SM00592 | |
| Domain | FAD-bd | 9.41e-04 | 6 | 150 | 2 | IPR002938 | |
| Domain | - | 9.41e-04 | 6 | 150 | 2 | 3.30.465.10 | |
| Domain | BRK_domain | 9.41e-04 | 6 | 150 | 2 | IPR006576 | |
| Domain | FAD_binding_3 | 9.41e-04 | 6 | 150 | 2 | PF01494 | |
| Domain | FAT | 9.41e-04 | 6 | 150 | 2 | PS51189 | |
| Domain | FATC | 9.41e-04 | 6 | 150 | 2 | PS51190 | |
| Domain | FAD_PCMH | 9.41e-04 | 6 | 150 | 2 | PS51387 | |
| Domain | CO_DH_flavot_FAD-bd_sub2 | 9.41e-04 | 6 | 150 | 2 | IPR016169 | |
| Domain | FAD-bd_2 | 9.41e-04 | 6 | 150 | 2 | IPR016166 | |
| Domain | FAT | 9.41e-04 | 6 | 150 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 9.41e-04 | 6 | 150 | 2 | IPR003151 | |
| Domain | FATC_dom | 9.41e-04 | 6 | 150 | 2 | IPR003152 | |
| Domain | PIK_FAT | 9.41e-04 | 6 | 150 | 2 | IPR014009 | |
| Domain | BRK | 9.41e-04 | 6 | 150 | 2 | PF07533 | |
| Domain | FATC | 9.41e-04 | 6 | 150 | 2 | SM01343 | |
| Domain | - | NDST1 MCM6 AK9 NLRP2 DHX30 LRGUK LONP1 EEF2 TRANK1 SMARCA2 NAV2 SMARCA4 DDX23 ABCC2 SMC1B | 9.98e-04 | 746 | 150 | 15 | 3.40.50.300 |
| Domain | GPCR_kinase | 1.31e-03 | 7 | 150 | 2 | IPR000239 | |
| Domain | TPR_11 | 1.31e-03 | 7 | 150 | 2 | PF13414 | |
| Domain | P-loop_NTPase | NDST1 MCM6 AK9 NLRP2 DHX30 LRGUK LONP1 EEF2 TRANK1 KIF3B SMARCA2 NAV2 SMARCA4 DDX23 ABCC2 SMC1B | 1.32e-03 | 848 | 150 | 16 | IPR027417 |
| Domain | TPR-contain_dom | 1.34e-03 | 150 | 150 | 6 | IPR013026 | |
| Domain | ARM-like | 1.55e-03 | 270 | 150 | 8 | IPR011989 | |
| Domain | LRR_1 | 1.98e-03 | 219 | 150 | 7 | PF00560 | |
| Domain | - | 2.14e-03 | 222 | 150 | 7 | 1.25.10.10 | |
| Domain | Ribosomal_S5_D2-typ_fold | 2.53e-03 | 34 | 150 | 3 | IPR020568 | |
| Domain | TPR-like_helical_dom | 2.80e-03 | 233 | 150 | 7 | IPR011990 | |
| Domain | TPR | 3.87e-03 | 129 | 150 | 5 | SM00028 | |
| Domain | Kinase-like_dom | 4.40e-03 | 542 | 150 | 11 | IPR011009 | |
| Domain | TPR_repeat | 4.41e-03 | 133 | 150 | 5 | IPR019734 | |
| Domain | PI3/4_kinase_CS | 6.28e-03 | 15 | 150 | 2 | IPR018936 | |
| Domain | - | 6.59e-03 | 207 | 150 | 6 | 1.25.40.10 | |
| Domain | - | 7.14e-03 | 16 | 150 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 7.14e-03 | 16 | 150 | 2 | SM00146 | |
| Pubmed | EPPK1 INTS1 USP24 RPS16 MCM6 TBL3 XAB2 DHX30 LONP1 FASN GTF3C1 BYSL SMARCA2 SMARCA4 DDX23 CCAR2 PRKDC ATM | 1.13e-09 | 653 | 157 | 18 | 22586326 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CAND1 OGT ACACB INTS1 USP24 HLCS RPS16 MCM6 TBL3 XAB2 DHX30 TGM2 LONP1 FASN EEF2 EIF2B4 SMARCA2 SMARCA4 EIF3K DDX23 CCAR2 STIP1 PRPF38A PRKDC | 6.39e-09 | 1318 | 157 | 24 | 30463901 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SCFD2 OGT XDH GPRC5A XAB2 DHX30 PPP2R1B FASN GTF3C1 KIN SYTL4 SMARCA2 SMARCA4 EIF3K DDX23 CCAR2 MICAL3 PRKDC ATM PPP2R3C ARAP1 STK25 | 1.32e-08 | 1155 | 157 | 22 | 20360068 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DPH2 NDST1 EPPK1 GRK6 INTS1 FBXL12 TBC1D25 STK11IP DHX30 CCND3 FASN NBEAL2 TMEM268 NAV2 MICAL3 PRKDC PPP2R3C PREX1 D2HGDH PLK3 ARAP1 | 3.02e-08 | 1105 | 157 | 21 | 35748872 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAND1 PKP4 RPS16 MCM6 VPS16 TBL3 DHX30 TGM2 LONP1 FASN EEF2 GTF3C1 WDR11 MICAL2 EIF2B4 BYSL SMARCA2 SMARCA4 DDX23 CCAR2 PRPF38A PRKDC PALLD | 4.80e-08 | 1353 | 157 | 23 | 29467282 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CAND1 OGT CAND2 EARS2 RADX INTS1 FBXL12 RPS16 MCM6 TBL3 DHX30 PPP2R1B FASN EEF2 GTF3C1 WDR11 GLUD2 SMARCA4 DDX23 CCAR2 PRKDC STK25 | 5.85e-08 | 1257 | 157 | 22 | 37317656 |
| Pubmed | COL12A1 EPPK1 CAND1 EARS2 ACAD9 USP24 RPS16 APOB GPRC5A STK11IP TBL3 XAB2 DHX30 JAK1 DNAAF5 FASN EEF2 CCAR2 STIP1 PRKDC PALLD STK25 | 1.01e-07 | 1297 | 157 | 22 | 33545068 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 KDM5C XAB2 FASN EEF2 GTF3C1 SMARCA4 CCAR2 STIP1 PRKDC PALLD | 3.69e-07 | 332 | 157 | 11 | 32786267 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 ACACB ACAD9 KDM5C SPG11 AK9 TRANK1 GTF3C1 NBEAL2 NAV2 DDX23 MICAL3 ATM | 4.65e-07 | 497 | 157 | 13 | 36774506 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NRDE2 CAND1 OGT INTS1 RPS16 XAB2 DHX30 SHKBP1 EEF2 GTF3C1 KIN SACS RBM15B SMARCA4 DDX23 PRPF38A PRKDC ATM PLXNB1 | 4.82e-07 | 1082 | 157 | 19 | 38697112 |
| Pubmed | CCDC8 CAND1 NAGK ACAD9 RPS16 MCM6 SPG11 LSM3 DHX30 PPP2R1B LONP1 FASN EEF2 GTF3C1 WDR11 LRRC1 BYSL EIF3K CCAR2 STIP1 PRKDC | 6.88e-07 | 1335 | 157 | 21 | 29229926 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 7.53e-07 | 357 | 157 | 11 | 37059091 | |
| Pubmed | ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. | 8.97e-07 | 5 | 157 | 3 | 17599403 | |
| Pubmed | Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | 8.97e-07 | 5 | 157 | 3 | 37163372 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 18316419 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CCDC8 EPPK1 CAND1 GRK6 INTS1 MCM6 TBL3 XAB2 DHX30 LONP1 FASN GTF3C1 SACS SMARCA4 DDX23 CCAR2 STIP1 PRKDC | 9.71e-07 | 1024 | 157 | 18 | 24711643 |
| Pubmed | EPPK1 CAND1 ACAD9 PKP4 DHX30 CCND3 DNAAF5 TGM2 LONP1 MICAL2 SMARCA2 NAV2 SMARCA4 CYB5R1 | 1.24e-06 | 634 | 157 | 14 | 34591612 | |
| Pubmed | CAND1 USP24 RPS16 MCM6 TBL3 DHX30 DNAAF5 LONP1 FASN EEF2 SMARCA4 CCAR2 STIP1 PRKDC | 1.34e-06 | 638 | 157 | 14 | 33239621 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPPK1 CAND1 OGT TUBB8 USP24 RPS16 MCM6 XAB2 DHX30 LONP1 FASN EEF2 EIF2B4 BYSL SMARCA4 EIF3K DDX23 CCAR2 STIP1 PRKDC PALLD | 1.73e-06 | 1415 | 157 | 21 | 28515276 |
| Pubmed | 2.15e-06 | 320 | 157 | 10 | 28685749 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CAND1 NAGK OGT CAND2 ACAD9 FBXL12 MCM6 SHKBP1 DNAAF5 PPP2R1B FASN GTF3C1 EIF2B4 LRRC1 CCAR2 STIP1 PRKDC | 2.18e-06 | 974 | 157 | 17 | 28675297 |
| Pubmed | DPH2 CAND1 OGT ACAD9 KDM5C INTS1 MCM6 SPG11 VPS16 TBL3 XAB2 DHX30 CCND3 AURKC MFSD2A FASN DIO1 EIF3K STIP1 PPP2R3C | 2.48e-06 | 1327 | 157 | 20 | 32694731 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 CAND1 INTS1 USP24 PPP2R1B FASN LRRC1 SMARCA2 SMARCA4 DDX23 PRKDC ATM ARAP1 | 2.67e-06 | 582 | 157 | 13 | 20467437 |
| Pubmed | CCDC8 CAND1 ACACB RPS16 APOB GPRC5A AP4E1 EEF2 KIN WDR11 SYTL4 EIF2B4 PWWP3A CCAR2 PRKDC | 2.67e-06 | 777 | 157 | 15 | 35844135 | |
| Pubmed | CAND1 OGT TUBB8 RPS16 MCM6 TBL3 FASN EEF2 SMARCA4 CCAR2 STIP1 PALLD | 2.80e-06 | 494 | 157 | 12 | 26831064 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 10673501 | ||
| Pubmed | CAND1 OGT KDM5C INTS1 MCM6 TBL3 XAB2 LONP1 FASN EEF2 GTF3C1 SMARCA2 SMARCA4 DDX23 CCAR2 PRKDC ATM | 3.73e-06 | 1014 | 157 | 17 | 32416067 | |
| Pubmed | CAND1 OGT CAND2 EARS2 RADX FBXL12 MCM6 STK11IP DNAAF5 WDR11 GLUD2 DDX23 STK25 | 4.14e-06 | 606 | 157 | 13 | 36538041 | |
| Pubmed | OGT USP24 RPS16 TBL3 DHX30 FASN EEF2 GTF3C1 SMARCA2 SMARCA4 EIF3K PRKDC PALLD | 4.85e-06 | 615 | 157 | 13 | 31048545 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 8.10e-06 | 104 | 157 | 6 | 31240132 | |
| Pubmed | SCFD2 CAND1 CAND2 TUBB8 ACAD9 CCND3 DNAAF5 PPP2R1B LONP1 FASN EEF2 GTF3C1 EIF2B4 EIF3K DDX23 CCAR2 MICAL3 STIP1 PRKDC ATM | 8.34e-06 | 1440 | 157 | 20 | 30833792 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CCDC8 CAND1 RADX RPS16 TBL3 DHX30 GTF3C1 KIN EIF2B4 BYSL RBM15B SMARCA4 CCAR2 PRKDC | 9.74e-06 | 759 | 157 | 14 | 35915203 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CAND2 ACACB ACAD9 INTS1 HLCS SHKBP1 PPP2R1B LONP1 LRRC1 CCAR2 STIP1 PRKDC | 1.25e-05 | 573 | 157 | 12 | 28330616 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SGSM1 CAND1 OGT STAP2 ZSWIM1 SHKBP1 CCND3 DNAAF5 ARHGAP6 PPP2R1B GTF3C1 KLF7 WDR11 MICAL2 EIF2B4 LRRC1 SMARCA2 MICAL3 ARAP1 DOP1A | 1.35e-05 | 1489 | 157 | 20 | 28611215 |
| Pubmed | 1.45e-05 | 11 | 157 | 3 | 11551930 | ||
| Pubmed | 1.45e-05 | 11 | 157 | 3 | 11709713 | ||
| Pubmed | Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. | 1.45e-05 | 11 | 157 | 3 | 16400328 | |
| Pubmed | NRDE2 CAND1 OGT TUBB8 ACAD9 PKP4 INTS1 TBL3 XAB2 LSM3 DHX30 SHKBP1 WDR11 BYSL RBM15B SMARCA2 EIF3K STIP1 PRPF38A PREX1 | 1.46e-05 | 1497 | 157 | 20 | 31527615 | |
| Pubmed | 1.48e-05 | 399 | 157 | 10 | 37536630 | ||
| Pubmed | 1.61e-05 | 403 | 157 | 10 | 35253629 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPPK1 PKP4 RPS16 GPRC5A TBL3 XAB2 DHX30 TGM2 FASN EEF2 GTF3C1 KIN WDR11 EIF2B4 BYSL RBM15B SMARCA4 PRKDC | 1.63e-05 | 1257 | 157 | 18 | 36526897 |
| Pubmed | 1.93e-05 | 12 | 157 | 3 | 15140983 | ||
| Pubmed | 1.93e-05 | 72 | 157 | 5 | 36376293 | ||
| Pubmed | ACAD9 RPS16 MCM6 VPS16 DHX30 JAK1 LONP1 EEF2 GTF3C1 EIF2B4 SMARCA4 PRKDC | 1.99e-05 | 601 | 157 | 12 | 33658012 | |
| Pubmed | Cell volume changes regulate slick (Slo2.1), but not slack (Slo2.2) K+ channels. | 2.02e-05 | 2 | 157 | 2 | 25347289 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 8670841 | ||
| Pubmed | Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis. | 2.02e-05 | 2 | 157 | 2 | 11231155 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 2.02e-05 | 2 | 157 | 2 | 23076393 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 25659036 | ||
| Pubmed | Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. | 2.02e-05 | 2 | 157 | 2 | 10464290 | |
| Pubmed | Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM. | 2.02e-05 | 2 | 157 | 2 | 27939942 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 15576411 | ||
| Pubmed | A functional -1 ribosomal frameshift signal in the human paraneoplastic Ma3 gene. | 2.02e-05 | 2 | 157 | 2 | 16407312 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 15240517 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 2.02e-05 | 2 | 157 | 2 | 33027072 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23872584 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 21487018 | ||
| Pubmed | Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. | 2.02e-05 | 2 | 157 | 2 | 26057167 | |
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 2.02e-05 | 2 | 157 | 2 | 23088494 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 20333683 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 34812766 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 2.02e-05 | 2 | 157 | 2 | 30478150 | |
| Pubmed | Slack and Slick K(Na) channels regulate the accuracy of timing of auditory neurons. | 2.02e-05 | 2 | 157 | 2 | 17344399 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 2.02e-05 | 2 | 157 | 2 | 25808524 | |
| Pubmed | Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress. | 2.02e-05 | 2 | 157 | 2 | 28232487 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19071136 | ||
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 2.02e-05 | 2 | 157 | 2 | 19144648 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 20085763 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12065055 | ||
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 2.02e-05 | 2 | 157 | 2 | 29391527 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 17189255 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 37634210 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22972376 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26774662 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 8208605 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26845140 | ||
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 2.02e-05 | 2 | 157 | 2 | 11163203 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 2.02e-05 | 2 | 157 | 2 | 12620226 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27039070 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 29848589 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36727301 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27682982 | ||
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 2.02e-05 | 2 | 157 | 2 | 9603422 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23276717 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27097303 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 34046694 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28038711 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 2.02e-05 | 2 | 157 | 2 | 23963727 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 25127855 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 2.02e-05 | 2 | 157 | 2 | 31375262 | |
| Pubmed | Deciphering the role of distinct DNA-PK phosphorylations at collapsed replication forks. | 2.02e-05 | 2 | 157 | 2 | 32674014 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 17075831 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 2.02e-05 | 2 | 157 | 2 | 32855269 | |
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 2.02e-05 | 2 | 157 | 2 | 22721696 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 18508913 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 21245310 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 11719516 | ||
| Interaction | NPTN interactions | CAND2 EARS2 TUBB8 INTS1 USP24 FBXL12 SPG11 DNAAF5 NBEAL2 ATM D2HGDH MIEF2 DOP1A | 2.47e-07 | 278 | 155 | 13 | int:NPTN |
| Interaction | EEF1AKMT3 interactions | TUBB8 KDM5C SPG11 ALS2CL NLRP2 XAB2 SHKBP1 DNAAF5 GTF3C1 MOCS3 NBEAL2 CCAR2 STIP1 ARAP1 | 8.90e-07 | 364 | 155 | 14 | int:EEF1AKMT3 |
| Interaction | P2RY10 interactions | 1.63e-06 | 106 | 155 | 8 | int:P2RY10 | |
| Interaction | GPR45 interactions | EARS2 TUBB8 INTS1 FBXL12 SPG11 STK11IP JAK1 DNAAF5 PPP2R1B NBEAL2 LRRC1 ATM | 3.71e-06 | 300 | 155 | 12 | int:GPR45 |
| Interaction | HCST interactions | 4.34e-06 | 205 | 155 | 10 | int:HCST | |
| Interaction | BSG interactions | CAND1 OGT CAND2 EARS2 TUBB8 GRK6 INTS1 FBXL12 TBL3 DNAAF5 PPP2R1B LONP1 FASN NBEAL2 BYSL DDX23 ATM | 7.59e-06 | 631 | 155 | 17 | int:BSG |
| Interaction | SLX4 interactions | CAND1 OGT ACACB TUBB8 RPS16 MCM6 XAB2 DHX30 FASN EEF2 KIN LRRC1 SMARCA4 CCAR2 PRKDC PLK3 | 8.98e-06 | 572 | 155 | 16 | int:SLX4 |
| Interaction | SIRT7 interactions | EPPK1 INTS1 USP24 RPS16 MCM6 TBL3 XAB2 DHX30 LONP1 FASN GTF3C1 BYSL SMARCA2 SMARCA4 DDX23 CCAR2 PRKDC ATM | 1.73e-05 | 744 | 155 | 18 | int:SIRT7 |
| Interaction | FPR1 interactions | 1.84e-05 | 147 | 155 | 8 | int:FPR1 | |
| Interaction | MAS1 interactions | 5.32e-05 | 86 | 155 | 6 | int:MAS1 | |
| Interaction | TOP3B interactions | DPH2 NDST1 EPPK1 GRK6 INTS1 FBXL12 RPS16 TBC1D25 APOB STK11IP DHX30 CCND3 LONP1 FASN FASTK NBEAL2 TMEM268 BYSL NAV2 MICAL3 PRKDC PPP2R3C PREX1 D2HGDH PLK3 ARAP1 | 5.46e-05 | 1470 | 155 | 26 | int:TOP3B |
| Interaction | DIO1 interactions | 5.88e-05 | 2 | 155 | 2 | int:DIO1 | |
| Interaction | GPR17 interactions | 6.98e-05 | 283 | 155 | 10 | int:GPR17 | |
| Interaction | SMC3 interactions | CCDC8 INTS1 MCM6 TBC1D25 FASN GTF3C1 SMARCA2 SMARCA4 STIP1 PRKDC ATM SMC1B | 7.75e-05 | 408 | 155 | 12 | int:SMC3 |
| Interaction | FKBP5 interactions | OGT RADX GRK6 MCM6 AURKC PPP2R1B FASN SACS FASTK STIP1 PRKDC PALLD | 8.90e-05 | 414 | 155 | 12 | int:FKBP5 |
| Interaction | USP18 interactions | 9.80e-05 | 60 | 155 | 5 | int:USP18 | |
| Interaction | MCM8 interactions | 1.06e-04 | 61 | 155 | 5 | int:MCM8 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 2.09e-04 | 155 | 158 | 5 | chr1p32 | |
| Cytoband | 3p21.31 | 4.10e-04 | 100 | 158 | 4 | 3p21.31 | |
| GeneFamily | Potassium sodium-activated channel subfamily T | 2.40e-05 | 2 | 89 | 2 | 856 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ATP13A4 COL12A1 GPRC5A ALS2CL KCNT2 MICAL2 NBEAL2 LRRC1 NAV2 PALLD | 1.65e-09 | 190 | 158 | 10 | 30b50d183d7649146eb1e79b47ba897355f1998a |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-08 | 187 | 158 | 9 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NDST1 ATP13A4 COL12A1 GPRC5A ALS2CL KCNT2 MICAL2 NBEAL2 NAV2 | 3.60e-08 | 196 | 158 | 9 | eb68f7954e7c2f86d05e740e95b6e74805a6053f |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 3.07e-07 | 183 | 158 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-07 | 184 | 158 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-07 | 184 | 158 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.34e-07 | 185 | 158 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 4.26e-07 | 191 | 158 | 8 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.98e-07 | 195 | 158 | 8 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-07 | 197 | 158 | 8 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.99e-06 | 174 | 158 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-06 | 175 | 158 | 7 | 3031f1eef3cfef8a7e5f57e567cb0868d06cac38 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.61e-06 | 179 | 158 | 7 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.61e-06 | 179 | 158 | 7 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-06 | 183 | 158 | 7 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 4.32e-06 | 184 | 158 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 4.64e-06 | 186 | 158 | 7 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.81e-06 | 187 | 158 | 7 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 4.81e-06 | 187 | 158 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.98e-06 | 188 | 158 | 7 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 5.16e-06 | 189 | 158 | 7 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.55e-06 | 196 | 158 | 7 | c57a95f8b4d8d6334f269d3c16246684f4222a3e | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.77e-06 | 197 | 158 | 7 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.23e-06 | 199 | 158 | 7 | b65fbfed4a9938820cf900afd350b4ecb789b7b3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-05 | 143 | 158 | 6 | 8f897278f9ccc82ae35e4f30c5f930b2a3eb509d | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.25e-05 | 170 | 158 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 171 | 158 | 6 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.95e-05 | 176 | 158 | 6 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.08e-05 | 177 | 158 | 6 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.08e-05 | 177 | 158 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.48e-05 | 180 | 158 | 6 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 4.76e-05 | 182 | 158 | 6 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 184 | 158 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.21e-05 | 185 | 158 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 5.37e-05 | 186 | 158 | 6 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 5.53e-05 | 187 | 158 | 6 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.40e-05 | 192 | 158 | 6 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 194 | 158 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 6.78e-05 | 194 | 158 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 194 | 158 | 6 | 54975e663ed4414b99b3c9a1aa6335613946470f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.98e-05 | 195 | 158 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.98e-05 | 195 | 158 | 6 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.98e-05 | 195 | 158 | 6 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.18e-05 | 196 | 158 | 6 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.38e-05 | 197 | 158 | 6 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.38e-05 | 197 | 158 | 6 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.38e-05 | 197 | 158 | 6 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.38e-05 | 197 | 158 | 6 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.59e-05 | 198 | 158 | 6 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 200 | 158 | 6 | c6f211bbadd0c9be776c58807249e06764df47dc | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 200 | 158 | 6 | 5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.02e-05 | 200 | 158 | 6 | e3a80626941363bfc9d97ef906d38c97080aecb1 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 139 | 158 | 5 | 39f3c28f89c37bb8cc049c56d2948ea906fb3d86 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 139 | 158 | 5 | 4efab4421e3448880a1dcf981f6a65131b038010 | |
| Disease | neutrophil count | SCFD2 NDST1 KDM5C BCORL1 CDH23 RPS16 MCM6 LSM3 CCND3 AP4E1 GTF3C1 MICAL2 NBEAL2 UHMK1 PRKDC AGBL2 PPP2R3C PREX1 CCDC63 | 5.98e-05 | 1382 | 147 | 19 | EFO_0004833 |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.44e-04 | 5 | 147 | 2 | C3281201 | |
| Disease | muscular disease (implicated_via_orthology) | 2.44e-04 | 5 | 147 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 2.90e-04 | 26 | 147 | 3 | OBA_2045191 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 3.16e-04 | 65 | 147 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | LDL cholesterol change measurement | 5.09e-04 | 7 | 147 | 2 | EFO_0007804 | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 5.09e-04 | 7 | 147 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 6.02e-04 | 206 | 147 | 6 | C0152013 | |
| Disease | Profound Mental Retardation | 6.75e-04 | 139 | 147 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 6.75e-04 | 139 | 147 | 5 | C0025363 | |
| Disease | Mental deficiency | 6.75e-04 | 139 | 147 | 5 | C0917816 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 6.77e-04 | 8 | 147 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | Kartagener Syndrome | 7.05e-04 | 35 | 147 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 7.05e-04 | 35 | 147 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 7.05e-04 | 35 | 147 | 3 | C4317124 | |
| Disease | Primary ciliary dyskinesia | 7.67e-04 | 36 | 147 | 3 | cv:C0008780 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 8.67e-04 | 9 | 147 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.95e-04 | 148 | 147 | 5 | C0279702 | |
| Disease | Inherited neuropathies | 1.05e-03 | 40 | 147 | 3 | C0598589 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.13e-03 | 91 | 147 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | prostate cancer (is_marker_for) | 1.13e-03 | 156 | 147 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Adenoid Cystic Carcinoma | 1.60e-03 | 100 | 147 | 4 | C0010606 | |
| Disease | Primary Ciliary Dyskinesia | 1.67e-03 | 47 | 147 | 3 | C4551720 | |
| Disease | testosterone measurement | SCFD2 NRDE2 DCHS2 BCORL1 XDH KCTD11 MLYCD ARHGAP6 FASN WDR11 SYTL4 EIF2B4 SMARCA2 DGKI ARAP1 | 1.80e-03 | 1275 | 147 | 15 | EFO_0004908 |
| Disease | Coffin-Siris syndrome | 1.85e-03 | 13 | 147 | 2 | C0265338 | |
| Disease | cholestasis (biomarker_via_orthology) | 1.89e-03 | 49 | 147 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.16e-03 | 14 | 147 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | fibrinogen measurement | 2.19e-03 | 109 | 147 | 4 | EFO_0004623 | |
| Disease | cancer (implicated_via_orthology) | 2.31e-03 | 268 | 147 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | nervousness | 2.83e-03 | 16 | 147 | 2 | NCIT_C74532 | |
| Disease | carotid atherosclerosis | 2.83e-03 | 16 | 147 | 2 | EFO_0009783 | |
| Disease | C-reactive protein measurement | DCHS2 MC4R SPG11 APOB PGM5 MLYCD JAK1 NRBP2 TRANK1 DNAH17 EIF2B4 SMARCA4 MICAL3 ARAP1 | 2.88e-03 | 1206 | 147 | 14 | EFO_0004458 |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.00e-03 | 195 | 147 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Eye Abnormalities | 3.19e-03 | 17 | 147 | 2 | C0015393 | |
| Disease | Insulin Resistance | 3.37e-03 | 60 | 147 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 3.37e-03 | 60 | 147 | 3 | C0920563 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.53e-03 | 61 | 147 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 3.58e-03 | 18 | 147 | 2 | OBA_2045175 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.58e-03 | 18 | 147 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.91e-03 | 128 | 147 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.91e-03 | 128 | 147 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.91e-03 | 128 | 147 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.91e-03 | 128 | 147 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.91e-03 | 128 | 147 | 4 | C0007134 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.99e-03 | 19 | 147 | 2 | C1333991 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.99e-03 | 19 | 147 | 2 | EFO_0802076 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.99e-03 | 19 | 147 | 2 | C2936783 | |
| Disease | serum alanine aminotransferase measurement | COL12A1 BCORL1 STAP2 XDH APOB WDPCP MLYCD TRANK1 ABCC2 AGBL2 ARAP1 | 4.28e-03 | 869 | 147 | 11 | EFO_0004735 |
| Disease | age at initiation of smoking | 4.41e-03 | 66 | 147 | 3 | EFO_0021784 | |
| Disease | acetate measurement | 4.42e-03 | 20 | 147 | 2 | EFO_0010112 | |
| Disease | base metabolic rate measurement | 4.42e-03 | 20 | 147 | 2 | EFO_0007777 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 4.86e-03 | 21 | 147 | 2 | EFO_0022246 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YRLELEVPQARLLGL | 751 | Q99569 | |
| RNLLERIYPDSIQEL | 196 | A0A0G2JMD5 | |
| SLYPIAVLIDELRNE | 21 | P30154 | |
| LELQRRYRSLLVPSD | 241 | Q8N163 | |
| DDLLPLLIYVVSRAR | 881 | Q60I27 | |
| ARDLISRLLRYQPLE | 266 | Q9UQB9 | |
| ELYLRRNRIPSLAEL | 66 | O43822 | |
| RVLQSLLRLEERYVP | 26 | P30281 | |
| RIQIPKLLETLRRYD | 136 | Q6Y288 | |
| ILFADIPELYRRLDL | 1086 | Q4VNC1 | |
| RHLRLPTYQELEQEI | 741 | O95267 | |
| DRYLAVVKLLEARPL | 136 | O00155 | |
| PYERILRDTRILLIF | 411 | Q9H845 | |
| VELVRYEPDLLRLLG | 1761 | Q5H9F3 | |
| LRRILLPLYEVDDLR | 176 | Q9GZX7 | |
| LEALATLLRPRYLDL | 161 | Q9BQC3 | |
| EYLLLSRNRLAELPA | 461 | P35858 | |
| YLPDIQERLVESLRL | 2196 | Q5JWR5 | |
| EEPREVLLRLYGAIL | 96 | Q9Y259 | |
| RIPQLLLERYVTEGR | 466 | Q7L2E3 | |
| IRIRVAIPLDYETVD | 411 | Q9H251 | |
| VEYRVALTEDRLPRL | 626 | Q76LX8 | |
| DPIIKRETLELLYRI | 386 | Q9UPM8 | |
| ILIEELRDRFPYLSE | 86 | Q9UJ70 | |
| PRRNEDFVLLLTYVL | 171 | Q8NFJ5 | |
| LARQLLLYDRPLKVE | 201 | Q8NDT2 | |
| VEVIFYLSDREPLRL | 36 | P23458 | |
| ILERPLISYTLQALE | 71 | A4D126 | |
| YIDRDPETIRRQLEL | 141 | O60870 | |
| YRLPAEDEVLLQKLR | 61 | Q969Q6 | |
| VEIVDPVDIYLNLLR | 191 | Q15124 | |
| VLAVQRYLLEDEPRD | 71 | Q6NSI4 | |
| EGRLKAREDLLLPIY | 2276 | O00763 | |
| LYELLLKTTRRPEEL | 561 | Q7RTW8 | |
| RYLSLLDTAVELELP | 356 | Q14296 | |
| IYPEELSRLHRLETL | 111 | Q7Z5L7 | |
| YLQLAEELIRPERNT | 46 | Q14566 | |
| EVLAERESIYRLLPQ | 436 | Q7RTP6 | |
| LEDRLHRQLTYDLLP | 446 | Q9NSY0 | |
| DLLLQLYLQRPELRV | 1801 | Q8N201 | |
| EVLGLVRVPLYTLRD | 136 | Q96DE0 | |
| RELRLYQTDLKEIPV | 121 | A6NIV6 | |
| DIVLTPLVAEALDRY | 1626 | Q2LD37 | |
| ELQIPDEEVLRLLYE | 136 | Q9BZ68 | |
| YRSRKELNPIVLLLD | 806 | Q5JUK3 | |
| AELKPLRADYLIARV | 626 | P50747 | |
| VLLQAEDRLRYALVP | 121 | O95822 | |
| IRDLLDTVLPHLYNE | 1041 | Q86VP6 | |
| REDVEYRPLTLNALL | 1741 | O43157 | |
| EPLDLIRLSLDERIY | 16 | P62310 | |
| LYAELEVELSPEVRR | 826 | Q9H7Z3 | |
| LSLPLDRYILVDIDD | 306 | P52848 | |
| LGLERTLLPDILYRD | 61 | Q2VPJ9 | |
| RDIIALNPLYRESVL | 301 | P36776 | |
| QVRYRPELDLVLRGI | 1306 | Q92887 | |
| CLELERYLQTEPRRI | 36 | O75840 | |
| LLPTEFSDYLRLQRE | 71 | Q8N5I3 | |
| LRDLRILAEEPIYIR | 341 | Q9NX02 | |
| ELREIEYIKNLPILR | 316 | Q96M69 | |
| ALEPIYSLELRFRVE | 686 | Q2VPB7 | |
| TRIELNDVVYLIRPD | 1091 | Q6UVM3 | |
| DRLTEYPLIINAIKR | 176 | Q6NUT2 | |
| PGRLIDVLENRYLVL | 526 | Q9BUQ8 | |
| EYPQVDDLLLRRLVK | 146 | Q9UI10 | |
| YLPREILNLIHLEEL | 226 | Q96CX6 | |
| LELRENLLTYLPDSL | 156 | Q9BTT6 | |
| PLDRESRDLYELLLV | 496 | Q6V1P9 | |
| QRLISEIEYRLERSP | 966 | Q8WX93 | |
| LLETDPDVVDYLLRR | 616 | O43182 | |
| VILILGVREQREPYE | 271 | Q8NA29 | |
| ALPERLYIIQEGRIL | 211 | P49895 | |
| PFLISDELRRVLLVE | 136 | Q9BRQ4 | |
| RPLLDSTILEYRDQI | 556 | O95876 | |
| LQDLLLEIYRSIGEP | 2001 | Q13315 | |
| IYLRDLKVEDIPLAR | 2691 | P04114 | |
| DLLLLETYRRILEVE | 456 | Q8NA47 | |
| LERLIPDTLYSVNLV | 1991 | Q99715 | |
| EANDIVLYLKPLRIL | 281 | Q9UFH2 | |
| DALELYRKVPNLRIL | 416 | O75912 | |
| LIATILDRVRDEYPQ | 1106 | Q4G0X9 | |
| LPEELLRNLYDSIRN | 226 | Q99418 | |
| RLNPDDVYIRVLLAL | 211 | Q5T764 | |
| EARVPQLSSLELRRY | 151 | Q9P0W0 | |
| RQLLYDELDEVNPRL | 146 | Q5U5Z8 | |
| ERPIRQILYLGDLLE | 96 | Q9UBQ5 | |
| IIDPLIYALRSQELR | 296 | P32245 | |
| DRALLELQLEPEELY | 161 | P13639 | |
| LIRIYPELLKRLDDV | 741 | Q86Y56 | |
| ERIVYRDLKPENILL | 306 | P32298 | |
| RIVYRDLKPENILLD | 306 | P43250 | |
| DPQLRLLLEVTYEAI | 76 | P49327 | |
| EDVDYLLIPREVRLA | 6 | Q9H0W5 | |
| LEQIEAEPRRQYLLL | 901 | O75155 | |
| VRDLLDDILPLLYQE | 1046 | O75155 | |
| DDILPLLYQETKIRR | 1051 | O75155 | |
| LRTKIAELERQYPAL | 686 | Q9NZ56 | |
| RSDLENVRDLALYLP | 3896 | Q9NZJ4 | |
| NLVLLPRVRDDVAEY | 251 | Q13895 | |
| ELRPILVTLDYIQFD | 1511 | Q9C0B2 | |
| IFLERNILVIPDLYL | 416 | P49448 | |
| SRDEILRYSRQLVLP | 56 | O95396 | |
| LPVERLYDIVTDLRA | 406 | Q8N465 | |
| ELLAERESLYRLLPQ | 436 | O94851 | |
| DLAIDTYRRAIELQP | 276 | O15294 | |
| RYPLTESQLALVRDI | 256 | Q16621 | |
| LLRAEADFYQIRPLL | 56 | Q693B1 | |
| LQDLYPVEAARLRAL | 331 | Q96C03 | |
| IPYLLRLRQIKDETL | 406 | Q9NP80 | |
| PLEELAYRRSLRVAL | 81 | Q2TAK8 | |
| ETLRYEIPESLLAQR | 426 | Q96C24 | |
| IQDELERYLIPIISI | 1281 | Q5TCS8 | |
| SVLLYRSAPEDLRLL | 1021 | Q8N1F8 | |
| KVSRLEAQLLLERYP | 156 | Q9UGK3 | |
| VYDRILDLRIATPQI | 506 | Q9HCS7 | |
| GLDPVEILQEREYRL | 336 | P51531 | |
| LLSDPTYRELIEQLR | 146 | P31948 | |
| EGQLSRPEELRLRIY | 211 | Q3MII6 | |
| VLLEIFSYLPVRDRI | 11 | Q9NXK8 | |
| LRLVLGYILLEDPQL | 1581 | Q6ZNJ1 | |
| LLELAQDIDYALLPR | 66 | Q9UL41 | |
| LTYLQLLERCVRDPE | 776 | P58107 | |
| IIPYLLEAVREGLQL | 2366 | Q8IVL1 | |
| INSLIYLSEELLRIP | 326 | Q7Z443 | |
| ILAKRLLILPQEEDY | 621 | Q8TCU6 | |
| LDPVEILQEREYRLQ | 361 | P51532 | |
| ILIQYDRTLLVADPR | 111 | P62249 | |
| YGLTPLVRRLQLREE | 101 | Q8TBC3 | |
| RTNEDYSPEELLILL | 461 | Q8WU76 | |
| LLPEYHQRVEVLRTL | 1051 | Q15477 | |
| YEVLRELLEAEPELL | 126 | A6NJG2 | |
| QLEAVQERYLSLLRP | 496 | A8MXQ7 | |
| ILREDLEELQARYPN | 221 | Q9UHQ9 | |
| VEYLDRLIPQALKIR | 446 | Q96E52 | |
| PLEETYIATILREIL | 111 | O00506 | |
| RDVLNPVYVERILLL | 391 | Q5JPH6 | |
| LVELDREVNYALVPR | 66 | P0CW24 | |
| EEKVSRYRELLVRLP | 1061 | Q96P48 | |
| YLRNVEELIPALDLL | 576 | Q96JI7 | |
| LLVEPVINSYLLAER | 566 | P21980 | |
| LAESALLEPQVRRYI | 81 | Q5VZI3 | |
| TLLEPEVRYYLRQIL | 156 | Q9H4B4 | |
| LLSKIREEYPDRIIN | 151 | Q3ZCM7 | |
| KDLRQYLILRNIPID | 121 | Q969K3 | |
| LALDYLDIKPINERL | 571 | Q8NDV3 | |
| PEARYRAENIVLLEL | 651 | O15066 | |
| LYEETRSHIPLLREL | 186 | P0DUX1 | |
| GVLLRREAPEELLAY | 736 | Q12788 | |
| EYLRLPEVQGVSRIL | 471 | Q9H269 | |
| RNLLERIYPDSIQEL | 196 | O60809 | |
| DIPRYENELSLRLVT | 596 | P47989 | |
| QLAHLVYRLREDTLP | 91 | Q9HBU9 | |
| ILPRLQKRYVLEEAE | 161 | Q8NAV1 | |
| PELLDLYTVNLHRIE | 926 | Q2NKQ1 | |
| PRLLQIIERYPEETL | 3466 | P78527 | |
| LTIPRLEELYNTRLG | 491 | Q7Z4N2 | |
| RLLLLAERYVITIED | 926 | Q9UPU5 | |
| LYQLANLEEPRITLR | 1086 | Q9UPU5 | |
| FYQLSLERPVERLLL | 181 | Q9BR11 | |
| YEEVRLNRLLCLDPV | 2621 | O15050 | |
| LLLYPREILILDLEV | 261 | Q9BZH6 | |
| RPDLQLQDRYEEIDL | 66 | Q12789 | |
| PVLRLLNVLDDDYLE | 321 | Q8TAS1 | |
| KIPNVERRILDLYSL | 101 | P41229 |